CompanyOverview|NYSE:MDT] Investors increasingly seek stable and resilient investments in today's volatile and economically ...

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

Medtronic offers a compelling long-term investment opportunity with solid revenue and earnings growth, driven by innovation ...

Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor ...

Medtronic plc has announced the U.S. Food and Drug Administration (FDA) has approved the Simplera Sync sensor for use with ...

US FDA approves Medtronic’s new Simplera Sync sensor for the MiniMed 780G system: Galway, Ireland Monday, April 21, 2025, ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration ...

Grateful for the Medtronic technology that helps his son manage type 1 diabetes, Ralph Winkler pours creative energy into ...

Time in range metrics were similar, if not better, among older vs younger adults with T1D using automated insulin delivery systems.